SPIO对定量肝脏MRI各技术影响的评估
对48例成人行3T肝脏MRI,对比SPIO给药前后2D/3D多回波梯度回波R2*、PDFF、MRS脂肪分数、T1 mapping及MRE肝硬度。SPIO使肝R2*升高约3.5倍,脾R2*升高约2倍;ME-GRE PDFF稳定,MRS脂肪分数可靠性下降;肝T1缩短约500 ms;MRE肝硬度无显著变化。
要点
- SPIO可致肝R2*大幅升高,高R2*时两种软件测量一致性变差。
- ME-GRE PDFF在SPIO后保持稳定,MRS脂肪定量可靠性下降。
- SPIO后肝T1明显缩短,MRE肝硬度无显著改变。
核心结论
- SPIO致肝R2*大幅升高、MRS脂肪定量可靠性下降、肝T1明显缩短,而ME-GRE PDFF相对稳定、MRE肝硬度无显著变化。
- SPIO可作为体内磁化率模型帮助理解定量肝脏MRI技术的磁化率依赖性。
研究设计与样本
- 回顾性研究,纳入48例成人,于3T MRI在SPIO给药前后重复检查。
- R2*与PDFF由2D和3D多回波梯度回波序列经MRQuantif和LiverLab处理获得。
- 同时评估MRS脂肪分数、可变翻转角T1 mapping及MRE肝硬度。
- 方法间一致性采用Pearson相关、组内相关系数与Bland-Altman分析,SPIO相关变化预测因素采用多变量线性回归。
关键影像表现/征象
- SPIO给药后肝R2*升高约3.5倍,脾R2*升高约2倍,以肝摄取为主。
- SPIO给药后LiverLab与MRQuantif测得R2*相关性仍强,但高R2*值下方法间一致性下降。
- ME-GRE脂肪分数在SPIO给药前后保持稳定,方法间一致性良好。
- MRS脂肪分数在SPIO给药后可靠性降低,脂肪分数出现升高,与ME-GRE PDFF相关性减弱。
- SPIO给药后肝T1值均匀缩短约500 ms,MRE肝硬度无显著变化。
诊断标准与关键数值
- SPIO后肝R2*升高约3.5倍,脾R2*升高约2倍,作为肝优势摄取的判断依据。
- SPIO后肝T1均匀缩短约500 ms,可作为T1 mapping受磁化率影响的参考变化量。
临床应用与阅片要点
- 常规使用超顺磁性铁对比剂时,ME-GRE PDFF比MRS脂肪定量更可靠,可用于脂肪分数随访。
- 高R2*条件下应警惕不同后处理软件测量一致性下降,报告随访R2*时需统一软件。
- 解读SPIO相关T1缩短时需与自身前后基线对比,避免误认为铁过载以外的改变。
局限性
- 研究为回顾性设计。
- SPIO作为受控磁化率模型,其结果未必可完整外推到所有含铁病变或内源性铁沉积情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To compare hepatic and splenic transverse relaxivity (R2*) derived from two-dimensional (2D) and three-dimensional (3D) multi-echo gradient-echo (ME-GRE) acquisitions before and after superparamagnetic iron oxide (SPIO) administration and to evaluate the effects of SPIO on proton density fat fraction (PDFF), MR spectroscopy (MRS)-derived PDFF, native T1 mapping, and magnetic resonance elastography (MRE)-derived liver stiffness.
MATERIALS AND METHODS: In this retrospective study, 48 adults underwent liver MRI at 3 T before and after SPIO administration. Hepatic and splenic R2* and PDFF were obtained from 2D and 3D ME-GRE acquisitions processed using MRQuantif and LiverLab. MRS-derived PDFF, native variable flip angle T1 mapping, and MRE-derived liver stiffness were assessed before and after SPIO administration. Agreement between methods was evaluated using Pearson correlation coefficients, intraclass correlation coefficients (ICC), and Bland-Altman analysis. Predictors of SPIO-induced changes were assessed using multivariable linear regression.
RESULTS: SPIO administration resulted in a marked increase in hepatic R2* (approximately 3.5-fold), exceeding the increase observed in the spleen (approximately 2-fold), consistent with predominant hepatic uptake. Correlation between LiverLab and MRQuantif R2* measurements remained strong; however, inter-method agreement deteriorated at higher R2* values after SPIO administration. ME-GRE-based PDFF measurements remained stable with preserved inter-method agreement. In contrast, MRS-derived PDFF demonstrated reduced reliability after SPIO administration, with apparent increases in fat fraction and weakened correlation with ME-GRE PDFF measurements. Native hepatic T1 values decreased uniformly by approximately 500 ms following SPIO administration. MRE-derived liver stiffness showed no significant change after SPIO administration.
CONCLUSION: Using SPIO as a controlled in vivo susceptibility model, this study provides an integrated evaluation of the susceptibility dependence of commonly used quantitative liver MRI biomarkers. SPIO-induced susceptibility effects substantially increase hepatic R2*, impair the reliability of MRS-based fat quantification, and markedly shorten native variable flip angle T1 measurements, while preserving the relative stability of ME-GRE-based PDFF and MRE-derived liver stiffness. These findings improve understanding of the susceptibility-related performance of quantitative liver MRI techniques and may help inform the interpretation and standardization of iron-sensitive MRI biomarkers.
引用
- Ba-Ssalamah, Poetter-Lang, Yitik, et al. SPIO-induced susceptibility effects on quantitative liver MRI: cross-method assessment of R2*, PDFF, T1 mapping, and MRE. Eur J Radiol. 2026. PMID: 42537343. doi:10.1016/j.ejrad.2026.113116
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。